Latest filing published 27 Jul 2026 for Lyell Immunopharma, Inc..
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Innovative Cellular Therapeutics Holdings Ltd: trading record in brief
Innovative Cellular Therapeutics Holdings Ltd appears in our data through filings on Lyell Immunopharma, Inc. shares, published by SEC (Form 4). In total, 4 filings cover trades dated from 16 July 2026 to 27 July 2026.
Every open-market trade on record is a sale: 2 sales worth €239.
On 27 July 2026 came the latest disclosure, a transaction in Lyell Immunopharma, Inc. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Innovative Cellular Therapeutics Holdings Ltd
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 38,500 shares0Common StockSEC:0001140361-26-029791:0
- 44,000 shares0Common StockSEC:0001140361-26-029817:0
- 10 shares@ US$13.700.0000% mcap50.0% of flowCommon StockSEC:0001140361-26-028955:0
- 10 shares@ US$13.730.0000% mcap100.0% of flowCommon StockSEC:0001140361-26-028846:0
4 of 4 declarations
